课题基金 / 基金详情

Epigenetic factors affecting the anti-mycobacterial immune response of people living with HIV

Epigenetic factors affecting the anti-mycobacterial immune response of people living with HIV
影响艾滋病毒感染者抗分枝杆菌免疫反应的表观遗传因素
批准号：
469078
负责人：
Schurr Erwin A
金额：
$69.2万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2027-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469078&lang=en
关键词：
Anti-Retroviral Drugs Genetics Hiv/Tuberculosis Multi-Omics

项目摘要

项目成果

Schurr Erwin A的其他基金

相似基金

相关文献

中文摘要
翻译
结核病(TB)是艾滋病毒携带者中最常见的疾病。2019年，估计有140万人死于结核病，其中包括20.8万名人类免疫缺陷病毒(HIV)携带者。在估计的1000万股
英文摘要
Tuberculosis (TB) is the most frequent illness among people living with HIV. In 2019, there were an estimated 1.4 million deaths caused by TB, which included 208,000 people living with the human immunodeficiency virus (HIV). Of the estimated 10 million pe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of anti-retroviral therapy in the increased rate of COVID-19 mortality of people living with HIV
From Molecules to Patients to Policies Symposium
Host genetic dissection of mycobacterial infection phenotypes
The genetic determinants of human anti-mycobacterial immune reactivity
国内基金
海外基金
Journal of Genetics and Genomics